ALDOCLOR-250 Drug Patent Profile
✉ Email this page to a colleague
When do Aldoclor-250 patents expire, and what generic alternatives are available?
Aldoclor-250 is a drug marketed by Merck and is included in one NDA.
The generic ingredient in ALDOCLOR-250 is chlorothiazide; methyldopa. There are forty-two drug master file entries for this compound. Additional details are available on the chlorothiazide; methyldopa profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALDOCLOR-250?
- What are the global sales for ALDOCLOR-250?
- What is Average Wholesale Price for ALDOCLOR-250?
Summary for ALDOCLOR-250
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | ALDOCLOR-250 at DailyMed |
US Patents and Regulatory Information for ALDOCLOR-250
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | ALDOCLOR-250 | chlorothiazide; methyldopa | TABLET;ORAL | 016016-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
